2005
DOI: 10.1073/pnas.0409496102
|View full text |Cite
|
Sign up to set email alerts
|

Holliday junction-binding peptides inhibit distinct junction-processing enzymes

Abstract: Holliday junctions (HJ) are the central intermediates in both homologous recombination and site-specific recombination performed by tyrosine recombinases such as the bacteriophage Integrase (Int) protein. Previously, our lab identified peptide inhibitors of Int-mediated recombination that prevent the resolution of HJ intermediates. We now show that two of these inhibitors bind HJ DNA in the square-planar conformation even in the absence of Int protein. The peptides prevent unwinding of branched DNA substrates … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
89
2

Year Published

2006
2006
2014
2014

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 46 publications
(93 citation statements)
references
References 51 publications
2
89
2
Order By: Relevance
“…The peptides have been characterized extensively and inhibit recombination by binding to the HJ intermediate and by preventing further catalysis (4,20,21), probably by altering the three-dimensional structure of the junction, moving the path of the phosphodiester backbone away from Int's active site (16). Because it binds HJ and, with lesser affinity and stability, other branched DNA intermediates (21), the peptide wrwycr inhibits a number of HJ processing enzymes in a structure-selective manner (20,21). This peptide has also been shown to have antimicrobial activity (18) and inhibits Salmonella growing inside macrophages (L. Su, D. Hall, and A. Segall, unpublished data).…”
Section: Discussionmentioning
confidence: 99%
“…The peptides have been characterized extensively and inhibit recombination by binding to the HJ intermediate and by preventing further catalysis (4,20,21), probably by altering the three-dimensional structure of the junction, moving the path of the phosphodiester backbone away from Int's active site (16). Because it binds HJ and, with lesser affinity and stability, other branched DNA intermediates (21), the peptide wrwycr inhibits a number of HJ processing enzymes in a structure-selective manner (20,21). This peptide has also been shown to have antimicrobial activity (18) and inhibits Salmonella growing inside macrophages (L. Su, D. Hall, and A. Segall, unpublished data).…”
Section: Discussionmentioning
confidence: 99%
“…DTT severely curtails all of their activities, strongly suggesting that monomer peptides assemble into at least dimers and in some cases into higher multimers via disulfide bonds. Binding of the WRWYCR to Holliday junctions and inhibition of Int recombination is severely reduced by DTT 20,35 . Both cysteines within peptide WYCRCK are very important to its activity.…”
Section: Peptides Inhibit a Type Ia Topoisomerase I Or Restriction Enmentioning
confidence: 99%
“…While these lines of investigation show great promise, additional approaches are constantly being sought to yield a new generation of useful antimicrobial compounds. For instance, focusing on species-specific antibiotics rather than broad-spectrum antibiotics can result in important new agents (38), as could targeting bacterial transcription factors (5) or different processes, such as Holliday junction processing (21,31) and quorum sensing (24), or even targeting host factors that support pathogen growth (33). Another approach, examined here, involves potentiating existing antibiotics by identifying targets for increasing susceptibility to specific antimicrobials.…”
mentioning
confidence: 99%
“…However, the spread of antibiotic-resistant microorganisms has reached an alarming point (1,11,35), prompting renewed efforts to find new antibiotics by detecting new targets through genomics, altering existing antibiotics, screening chemical (e.g., see reference 9) or peptide (21,31) libraries for specific inhibitors (e.g., see reference 9), or finding new sources of antibiotics via metagenomics (e.g., see reference 53). While these lines of investigation show great promise, additional approaches are constantly being sought to yield a new generation of useful antimicrobial compounds.…”
mentioning
confidence: 99%